Daily Archives: January 18, 2018
P029 ENDOCYTOSCOPIC FINDINGS PREDICT RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS DURING LONG-TERM FOLLOW-UP NO LESS THAN 5 YEARS
This study was conducted to explore the association of endocytoscopy (EC) findings with inflammatory activity and clinical course in ulcerative colitis (UC). EC was conducted for mild to moderate UC 32 cases from January 2010 to August 2016. The EC fin… Continue reading
P127 ULCERATIVE COLITIS AND PAPILLARY THYROID CARCINOMA – IS THERE AN ASSOCIATION?
A 26-year-old male with ulcerative pancolitis diagnosed 11 years before, with episodes of severe colitis and steroid-dependent disease, was initially managed with azathioprine and infliximab, latter switched to adalimumab due to an infusion reaction. F… Continue reading
P028 DYSBIOSIS DRIVEN LUMINAL MALMETABOLISM INCREASES THE RISK OF C. DIFFICLILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS
Clostridium difficile infection (CDI) is recognized as a major clinical complication in patients with ulcerative colitis (UC). However, the mechanism associated with increased susceptibility to C. difficile in UC patients remains poorly understood. Giv… Continue reading
P123 THE TRANS-GOLGI NETWORK PROTEIN AFTIPHILIN MAINTAINS COLONIC EPITHELIAL PERMEABILITY AND MUCOSAL INTEGRITY THROUGH BETA CATENIN DURING INFLAMMATION
Barrier function of colonic epithelium is compromised in IBD patients and contributes to colonic inflammation. Previously, we showed that aftiphilin (AFTPH) is significantly downregulated in colonic biopsies from UC patients and involved in receptor re… Continue reading
15 DISRUPTION OF FOXP3-EZH2 INTERACTION BY GENETIC MUTATION OR SIGNALING-INDUCED INACTIVATION REPRESENTS A NOVEL PATHOBIOLOGICAL MECHANISM IN INFLAMMATORY BOWEL DISEASE
While FOXP3+ regulatory T cell (Treg) dysfunction has been linked to human inflammatory bowel disease (IBD), molecular mechanisms for disease pathophysiology are unclear. The transcription factor FOXP3 via histone methyltransferase EZH2 suppresses infl… Continue reading
P027 DIFFERENTIAL BINDING OF RBPJ AND CUX1 TO IBD CAUSAL SNP RS1887428 MODIFIES EXPRESSION OF JAK2
Recently, genetic variants conferring risk for IBD were fine-mapped to single variant resolution. Eight of these causal variants resulted in amino acid substitutions while ten were non-coding. The mechanism by which these non-coding causal variants con… Continue reading
P115 THE IBD CANDIDATE GENE, PTPN2, RESTRICTS INTESTINAL BARRIER DEFECTS AND CLAUDIN-2 EXPRESSION VIA STAT INHIBITION
Loss-of-function mutations in the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene locus increase IBD susceptibility. We reported that PTPN2 knockdown (PTPN2-KD) in intestinal epithelial cells (IECs): (i) increased IFN-g activation of STAT… Continue reading
P026 DEVELOPMENT OF A PREFERENCE-WEIGHTED SYMPTOM SCALE FOR INFLAMMATORY BOWEL DISEASE
Practicing patient-centric care by incorporating patient preferences in IBD care is increasingly recognized to be important. However, existing IBD disease activity measures do not incorporate patient perspective. Here, we describe the development of a … Continue reading
P111 STRICTURING CROHN’S DISEASE OR A COMPLICATED MECKEL’S DIVERTICULUM WITH SMALL BOWEL STRICTURE?
Distinguishing between inflamed Meckel’s diverticulum (MD) and ileal Crohn’s disease (CD) can be challenging. We present a case of suspected MD in a patient with CD. Continue reading